SEC Form 4 · accession 0001140361-15-007641
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett Sandercock
Officer — Chief Financial Officer
Period of report
Feb 13, 2015
Accepted (ET)
Feb 17, 2015 · 7:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Feb 13, 2015 | M | 100,000 | $15.52 | A | 160,913 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed NQ Stock OptionsF2 | $15.52 | Feb 13, 2015 | M | 100,000 | D | Nov 20, 2009 | Nov 20, 2015 | ResMed Common Stock | 100,000 | 0 | D |
Explanation of responses
- F1This transaction represents the purchase hold price at the grant value of $15.52 per share.
- F2Represents date option first became exercisable.